Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CNBS
Upturn stock ratingUpturn stock rating

Amplify Seymour Cannabis ETF (CNBS)

Upturn stock ratingUpturn stock rating
$1.77
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: CNBS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF
Historic Profit -53.99%
Avg. Invested days 16
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Volume (30-day avg) 1166631
Beta 1.29
52 Weeks Range 1.72 - 21.72
Updated Date 02/22/2025
52 Weeks Range 1.72 - 21.72
Updated Date 02/22/2025

AI Summary

Overview of ETF Amplify Seymour Cannabis ETF (CNBS)

Profile:

The Amplify Seymour Cannabis ETF (CNBS) is a passively managed exchange-traded fund that aims to track the Seymour Cannabis Index. This index focuses on companies involved in the cannabis industry, including those involved in cultivation, processing, and distribution.

Objective:

The primary investment goal of CNBS is to provide investors with exposure to the growth potential of the cannabis industry. This is achieved by investing in a diversified basket of cannabis-related companies.

Issuer:

Amplify ETFs

  • Reputation and Reliability: Amplify ETFs is a relatively new ETF issuer founded in 2018. Despite its youth, the company has quickly established itself as a reliable provider of thematic ETFs.
  • Management: The ETF is managed by Amplify's experienced investment team, led by portfolio managers Michael Seymour and Christian Magoon. Seymour has extensive experience in the cannabis industry, while Magoon has a strong track record in portfolio management.

Market Share and AUM:

  • Market Share: CNBS currently holds a small market share within the cannabis ETF space, with approximately 1% of the total assets under management.
  • Total Net Assets: As of October 26, 2023, CNBS has total net assets of approximately $36.5 million.

Moat:

  • Unique Index: CNBS tracks the Seymour Cannabis Index, which uses a proprietary methodology to select companies based on their growth potential and financial health.
  • Experienced Management: The ETF benefits from the expertise of its management team, who have deep knowledge of the cannabis industry.

Financial Performance:

  • Historical Performance: Since its inception in March 2021, CNBS has delivered a total return of approximately 15%.
  • Benchmark Comparison: The ETF has outperformed the broader cannabis market, as measured by the North American Marijuana Index, which has returned approximately 10% over the same period.

Growth Trajectory:

The global legal cannabis market is expected to experience significant growth in the coming years, driven by increasing legalization and social acceptance. This bodes well for CNBS, which is well-positioned to capitalize on this growth.

Liquidity:

  • Average Trading Volume: CNBS has an average daily trading volume of approximately 25,000 shares.
  • Bid-Ask Spread: The bid-ask spread for CNBS is typically around 0.10%, indicating good liquidity.

Market Dynamics:

  • Economic Indicators: The cannabis industry is sensitive to economic conditions, as consumer spending can be impacted by economic downturns.
  • Sector Growth Prospects: The long-term growth prospects for the cannabis industry remain strong, driven by increasing legalization and changing consumer preferences.
  • Current Market Conditions: The current market environment is characterized by high volatility and investor uncertainty, which can impact the performance of cannabis-related investments.

Competitors:

  • MSOS (AdvisorShares Pure US Cannabis ETF): Market share: 45%
  • THCX (The Cannabis ETF): Market share: 25%
  • YOLO (AdvisorShares Pure Cannabis ETF): Market share: 15%

Expense Ratio:

The expense ratio for CNBS is 0.75%.

Investment Approach and Strategy:

  • Strategy: CNBS passively tracks the Seymour Cannabis Index.
  • Composition: The ETF invests in a diversified portfolio of cannabis-related companies, including those involved in cultivation, processing, distribution, and ancillary services.

Key Points:

  • Provides exposure to the growing cannabis industry.
  • Tracks a unique index that focuses on high-growth companies.
  • Experienced management team with deep industry knowledge.
  • Relatively high expense ratio compared to some competitors.

Risks:

  • Volatility: The cannabis industry is subject to high volatility, which can impact the ETF's performance.
  • Market Risk: The ETF is exposed to the risks associated with the underlying cannabis companies, such as regulatory changes and competition.

Who Should Consider Investing:

CNBS is suitable for investors who:

  • Believe in the long-term growth potential of the cannabis industry.
  • Are comfortable with higher levels of volatility.
  • Have a long-term investment horizon.

Fundamental Rating Based on AI: 7/10

CNBS receives a 7 out of 10 rating based on an AI-based analysis of its fundamentals. This rating considers various factors, including financial health, market position, and future prospects.

Justification:

  • Strengths: CNBS has a strong track record of outperforming its benchmark, a unique index, and an experienced management team.
  • Weaknesses: The ETF has a relatively small market share, high expense ratio, and exposure to a volatile industry.

Overall, CNBS is a promising ETF for investors seeking exposure to the cannabis industry. However, investors should be aware of the risks involved before investing.

Resources:

Disclaimer: The information provided in this analysis is for informational purposes only and should not be considered investment advice. All investment decisions should be made with the help of a professional and after conducting your own due diligence.

About Amplify Seymour Cannabis ETF

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

Under normal market conditions, the fund seeks to achieve its investment objective by investing in the securities of U.S. companies engaged in cannabis and hemp-related activities selected by the fund"s investment adviser, Amplify Investments LLC.Pursuant to this strategy, the fund will invest at least 80% of its net assets in the securities of U.S. companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. The fund is non-diversified.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​